Adolescent Interest in Long-Acting HIV Therapy in Cameroon, 2024

248 adolescents with perinatal HIV infection in Cameroon were surveyed in November 2024 to assess interest in long-acting injectable antiretroviral therapy. The data includes sociodemographic characteristics, clinical markers like viral load and CD4 counts, and factors influencing treatment preferences. The dataset was collected by Yagai Bouba and published under a CC-BY-4.0 license.

Use Cases

• Analyze factors associated with interest in long-acting therapy based on sociodemographic and clinical variables.
• Model predictors of treatment preference based on fear of injection and prior awareness levels.
• Assess disparities in treatment interest based on variables like stigma, disclosure status, and adherence history.

Strengths

• Data from 248 participants provides a substantive sample for analysis.
• Includes key clinical outcomes like viral undetectability (71.6%) and CD4 counts (72.5% ≥500 cells/mm³).
• Survey conducted across four paediatric HIV clinics in a defined region (Centre region, Cameroon).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data collection was limited to a single month (November 2024) and one region of Cameroon.

Provenance

Source

figshare

Collection Method

Cross-sectional study using structured questionnaires administered at four paediatric HIV clinics.

Time Range

Data collected from 4 to 30 November 2024.

Freshness

Last updated 2026-05-15 17:29:26; freshness should be verified.

Geography

Centre region of Cameroon.